Fig. 3From: Stem cell-based therapy for pulmonary fibrosisMechanism of MSC-based therapy for PF. MSCs home to injured lungs, where they exert immunomodulatory and antifibrotic effects via paracrine actions and activate endogenous lung stem cells to promote the regeneration of the injured lungsBack to article page